Compounded tirzepatide
Sold by EmbraceRX · Injection, vial · every compounded tirzepatide record
What you actually pay
Per month
$179
| Medication · High-dose tirzepatide, starting price | $179 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| High-dose tirzepatide, starting price “Weight Loss Compounded GLP-1 · Tirzepatide Starting from $179” | Per month$179 | Charged today$179 |
We earn nothing from this link. EmbraceRX has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “You can always login to your account before your products ship to change your address, method of payment or to cancel your subscription.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from embracerx.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Each product's price is described as 'Starting from $X' with 'Price shown at checkout. Dose selection on the next step' — the exact per-dose price ladder beyond the starting figure is not published on these pages. The FAQ has a 'What states do we serve?' question with no rendered answer (accordion content not present in this tool's output), so states left not-found rather than guessed. Oral tirzepatide capsules are recorded under the enum's 'compounded tirzepatide' + form 'oral-tablet' since there is no distinct 'oral tirzepatide' enum value and no FDA-approved oral tirzepatide brand exists; the product page itself calls it 'Oral dual GIP/GLP-1 receptor agonist' with no brand name, consistent with a compounded oral formulation. Site prominently disclaims no association with Novo Nordisk/Eli Lilly brand products and states it does not supply Wegovy/Ozempic/Ozempic/Mounjaro/Saxenda.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.